Skip to Content
Texas State University

COVID-19 Vaccination Information

Vaccination is vital to the country’s efforts to bring the pandemic to an end. Vaccines have proven to be safe and effective with no evidence of any long-term side-effects. They continue to be highly effective in preventing serious illness, hospitalization and death. While some “breakthrough” infections have occurred in fully vaccinated persons, such cases represent only about 1% of all new COVID-19 infections.

Texas State provides Comirnaty (Pfizer-BioNTech), Moderna, and Johnson & Johnson (Janssen) vaccinations for faculty, staff and students. Vaccinations are available Monday-Friday at the Student Health Center.

Third Dose Vaccinations

Pfizer-BioNTech (Comirnaty) third doses:

Pfizer-BioNTech (Comirnaty) third doses, or "booster," vaccinations have been authorized for the following groups:

  • Severely immunocompromised persons with second dose received at least one month ago
  • Persons 65 and older with second dose received at least six months ago
  • Persons 18-64 years of age with underlying medical conditions at increased risk from COVID-19 with second dose received at least six months ago
  • Persons 18-64 years of age with increased risk for COVID-19 exposure due to an occupational setting such as healthcare workers, teachers, and childcare workers with second dose received at least six months ago

Moderna third doses:

Moderna third doses, or "booster," vaccinations have been authorized for moderately to severely immunocompromised persons who may have cancer, be undergoing chemotherapy, are recipients of organ transplants, or taking high-dose steroids or other medications that suppress the immune system.

Student Posing with a COVID-19 vaccine sticker

How to sign up for a COVID-19 vaccine at TXST

Schedule an appointment

Call the Student Health Center at 512.245.2161 to schedule an appointment. Comirnaty (Pfizer) and Johnson & Johnson vaccinations are available Monday – Friday at the Student Health Center for students, faculty, and staff.

Vaccination Events

Round Rock Campus
  • October 15 - Third Dose Pfizer-BioNTech and Flu Vaccine Event

San Marcos Campus
  • No Events Planned for the Month
Student wearing mask, signing a form at a vaccination event

Frequently Asked Questions

Expand All Content
  • Faculty, staff or students wanting to be vaccinated on campus can call the Student Health Center at 512.245.2161 to schedule an appointment. Vaccinations are available Monday – Friday at the Student Health Center.

    Email announcements will be sent to the university community when additional mass vaccination events are scheduled during the Fall semester. The e-mail will include a vaccination registration link to reserve a date and time for vaccination.

  • Comirnaty (Pfizer-BioNTech) and Moderna third dose vaccinations are available at Texas State University Student Health Center.

    Pfizer-BioNTech (Comirnaty) third doses:

    Pfizer-BioNTech (Comirnaty) third doses, or "booster," vaccinations have been authorized for the following groups:

    • Severely immunocompromised persons with second dose received at least one month ago
    • Persons 65 and older with second dose received at least six months ago
    • Persons 18-64 years of age with underlying medical conditions at increased risk from COVID-19 with second dose received at least six months ago
    • Persons 18-64 years of age with increased risk for COVID-19 exposure due to an occupational setting such as healthcare workers, teachers, and childcare workers with second dose received at least six months ago

    Moderna third doses:

    Moderna third doses, or "booster," vaccinations have been authorized for moderately to severely immunocompromised persons who may have cancer, be undergoing chemotherapy, are recipients of organ transplants, or taking high-dose steroids or other medications that suppress the immune system.

    Information on third doses, or "booster," vaccinations will be updated as new information becomes available.

  • Yes.

    Vaccines authorized or approved for use in the United States must adhere to strict standards for safety. Vaccine manufacturers must provide the Food and Drug Administration (FDA) with information on the vaccine’s effectiveness and safety, typically based on results from thousands of patients participating in clinical trials. The FDA reviews the information and issues an Emergency Use Authorization (EUA) for a vaccine if it has demonstrated its effectiveness and safety. Then, the CDC’s Advisory Committee on Immunization Practices (ACIP), which includes medical and public health experts, reviews the clinical data on the vaccine’s effectiveness and safety before determining whether to recommend the use of the vaccine. 

    The ACIP has recommended the use of the Pfizer-BioNTech, Moderna, and Janssen (Johnson & Johnson) vaccines. The FDA and CDC continue to monitor safety and long-term side effects.

  • None of the currently authorized vaccines are 100% effective in preventing infection.

    They are all slightly less effective in preventing infection against the Delta variant, but still highly effective in preventing serious illness, hospitalization and death.

    Breakthrough infections can occur in fully vaccinated persons, but they are likely to cause milder symptoms and are less likely to spread to others. 

    Vaccinated persons with breakthrough infections must still isolate for 10 days and close contacts must quarantine for 7 days with testing or 10 days without testing. Fully vaccinated persons exposed to a positive case do not have to quarantine or test unless they develop symptoms of COVID-19.

  • Yes, the CDC recommends that persons who have been previously infected with COVID-19 get vaccinated.

    It is unclear how long the natural immunity that develops after infection lasts. Because it is rare that a person infected with COVID-19 will be reinfected within 90 days due to their natural immunity, they can wait up to 90 days before getting vaccinated.

  • Most of the COVID-19 vaccines will require two doses to produce the optimum immune response and protection. Early data indicates that one dose of vaccine does not produce the optimum immune response and it is unclear how long immunity will last. Johnson & Johnson vaccine is a one dose vaccine.

  • Yes, even after completing the COVID-19 vaccine series, the use of face masks and social distancing should be continued.

    While the vaccination may prevent you from developing serious illness, it is unclear whether it prevents you from spreading the infection. The CDC and other medical experts will continue to assess the effect of vaccination on illness and spread.

  • No, COVID-19 vaccination is not required to work at Texas State at this time.

    Vaccination is strongly recommended to protect yourself from developing serious illness due to COVID-19. It may also help decrease the spread of the infection to others.

    Studies continue to assess all the potential benefits of vaccination.

  • No, COVID-19 vaccination is not required to attend classes at Texas State at this time.

    Vaccination is strongly recommended to protect yourself from developing serious illness due to COVID-19. It may also help decrease the spread of infection to others.

    Studies continue to assess all the potential benefits of vaccination.

  • For other questions about the COVID-19 vaccine, check Frequently Asked Questions about COVID-19 Vaccination | CDC.

    Note:  Additional information will be added as it becomes available.

Roadmap

Texas State University’s Roadmap charts the path for keeping our community safe and our students advancing toward their educational goals.